World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
30466
World Ranking
13097
National Ranking
6686

Overview

Gerald P. Murphy was affiliated with the Roswell Park Cancer Institute in the United States. Their research contributions were primarily documented through several recent papers published between 2021 and 2022, reflecting involvement in editorial board issues for surgical oncology and prostate cancer journals.

Their recent publications include the following papers:

  • Issue Information, 2021, The Prostate
  • Issue Information, 2021, The Prostate
  • Issue Information - Ed Board, 2021, Journal of Surgical Oncology
  • Issue Information - Ed Board, 2022, Journal of Surgical Oncology
  • Issue Information - Ed Board, 2021, Journal of Surgical Oncology

Throughout their career, they frequently collaborated with several researchers, including:

  • David P. Winchester
  • Stephen Sener
  • Walley Temple
  • Perry Shen
  • Joel Baumgartner

The primary publication venues for their work included:

  • Journal of Surgical Oncology
  • The Prostate

Best Publications

  • LNCaP model of human prostatic carcinoma.

    J S Horoszewicz;S S Leong;E Kawinski;J P Karr

  • PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN

    M.C. Wang;L.A. Valenzuela;G.P. Murphy;T.M. Chu

  • Management and survival of female breast cancer: Results of a national survey by the American college of surgeons

    Takuma Nemoto;Josef Vana;Ramez N. Bedwani;Harvey W. Baker

  • Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

    G. Murphy;B. Tjoa;H. Ragde;G. Kenny

  • Prostate antigen: A new potential marker for prostatic cancer

    M. C. Wang;L. D. Papsidero;M. Kuriyama;L. A. Valenzuela

  • A prostate antigen in sera of prostatic cancer patients.

    L D Papsidero;M C Wang;L A Valenzuela;G P Murphy

  • Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer.

    Darrel E. Drachenberg;Abdel-Aziz A. Elgamal;Ron Rowbotham;Mary Peterson

  • Carcinoembryonic Antigen in Patients With Different Cancers

    Gustavo Reynoso;Tsann Ming Chu;Douglas Holyoke;Elias Cohen

  • Infusion of dendritic cells pulsed with HLA‐A2‐specific prostate‐specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone‐refractory metastatic disease

    G.P. Murphy;B.A. Tjoa;S.J. Simmons;J. Jarisch

  • Quantitation of Prostate-specific Antigen in Serum by a Sensitive Enzyme Immunoassay

    Kuriyama M;Wang Mc;Papsidero Ld;Killian Cs

  • Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides.

    B.A. Tjoa;S.J. Simmons;V.A. Bowes;H. Ragde

  • Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.

    Dutzu Rosner;Ramez N. Bedwani;Josef Vana;Harvey W. Baker

  • Prostate Antigen: A Marker for Human Prostate Epithelial Cells

    L D Papsidero;M Kuriyama;M C Wang;J Horoszewicz

  • Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen.

    Gerald P. Murphy;Abdel-Aziz A. Elgamal;Sai L. Su;David G. Bostwick

  • Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

    G.P. Murphy;B.A. Tjoa;S.J. Simmons;H. Ragde

  • Use of human prostate-specific antigen in monitoring prostate cancer.

    Manabu Kuriyama;Ming C. Wang;Ching-li Lee;Lawrence D. Papsidero

  • Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons.

    Joseph D. Schmidt;Joseph D. Schmidt;Curtis J. Mettlin;Curtis J. Mettlin;Nachimuthu Natarajan;Nachimuthu Natarajan;Barbara B. Peace;Barbara B. Peace

  • Current status of the therapy of advanced renal carcinoma.

    William J. Hrushesky;Gerald P. Murphy;Gerald P. Murphy

  • Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer.

    Killian Cs;Yang N;Emrich Lj;Vargas Fp

  • Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone

    Gerald P. Murphy;Sunmolu Beckley;Mark F. Brady;T. Ming Chu

Frequent Co-Authors

Avery A. Sandberg
Avery A. Sandberg Roswell Park Cancer Institute
David G. McLeod
David G. McLeod Uniformed Services University of the Health Sciences
Herman R. Menck
Herman R. Menck University of Southern California
David P. Winchester
David P. Winchester American College of Surgeons
Mark S. Soloway
Mark S. Soloway Memorial Hospital of South Bend
Judd W. Moul
Judd W. Moul Duke University
Alan W. Partin
Alan W. Partin Johns Hopkins University School of Medicine
Willet F. Whitmore
Willet F. Whitmore Memorial Sloan Kettering Cancer Center
Peter T. Scardino
Peter T. Scardino Memorial Sloan Kettering Cancer Center
Keerti V. Shah
Keerti V. Shah Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re passionate about medicine but seeking flexible alternatives to traditional pathways, a range of online degrees and career options in healthcare are worth exploring. For those interested in the administrative side, medical billing and coding online schools that accept financial aid can provide an accessible gateway into healthcare settings. These programs often allow for remote study and can help launch a career quickly.

For prospective nurses, some nursing school no entrance exam options eliminate common testing barriers, making entry into the nursing profession easier for many students.

Seeking leadership roles? Earning a health administration degree online can prepare you for executive and management positions in hospitals or healthcare organizations. These accelerated programs are designed for working adults balancing education with other commitments.

Registered Nurses aiming to become Family Nurse Practitioners can also benefit from streamlined education pathways, like rn to fnp programs that bridge associate degrees to advanced practice nursing careers. Exploring these related degrees can open multiple doors in the growing healthcare sector.

Best Scientists Citing Gerald P. Murphy

Recently Published Articles